{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:51:07Z","timestamp":1780447867717,"version":"3.54.1"},"reference-count":94,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T00:00:00Z","timestamp":1216080000000},"content-version":"vor","delay-in-days":745,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1111\/j.1365-2133.2006.07343.x","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T09:17:04Z","timestamp":1149758224000},"page":"1-16","source":"Crossref","is-referenced-by-count":54,"special_numbering":"supplement s2","title":["Update on the use of ciclosporin in immune-mediated dermatoses"],"prefix":"10.1093","volume":"155","author":[{"given":"C.E.M.","family":"Griffiths","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Katsambas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.C.","family":"Dijkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Y.","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Mrowietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Thestrup-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,7,15]]},"reference":[{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1582-4934.2004.tb00259.x","article-title":"Molecular mechanisms of neuroprotective action of immunosuppressants-facts and hypotheses","volume":"8","author":"Kaminska","year":"2004","journal-title":"J Cell Mol Med"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/clinchem\/45.9.1477","article-title":"Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect","volume":"49","author":"Stein","year":"1999","journal-title":"Clin Chem"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB3|cit3","first-page":"60","article-title":"Cyclosporin A for psoriasis","volume":"11","author":"Mrowietz","year":"1999","journal-title":"Dermatologic Ther"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1689","article-title":"Getting under the skin: immunogenetics of psoriasis","volume":"5","author":"Bowcock","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3310\/hta4400","article-title":"A systematic review of treatments for severe psoriasis","volume":"4","author":"Griffiths","year":"2000","journal-title":"Health Tech Assess"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.1988.tb03248.x","article-title":"Psoriasis","volume":"119","author":"Fry","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.0906-6705.2005.00294.x","article-title":"In vitro culture of skin-homing T lymphocytes from inflammatory skin diseases","volume":"14","author":"Bang","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2133.1995.tb05019.x","article-title":"The effect of severe psoriasis on the quality of life of 369 patients","volume":"132","author":"Finlay","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1468-3083.1996.tb00611.x","article-title":"Measures of the effect of adult severe atopic eczema on quality of life","volume":"7","author":"Finlay","year":"1996","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-4362.2002.01436.x","article-title":"Atopic dermatitis is associated with a decrement in health-related quality of life","volume":"41","author":"Kiebert","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/000992280204100505","article-title":"Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment","volume":"41","author":"Paller","year":"2002","journal-title":"Clin Pediatr"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","article-title":"Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction","volume":"9","author":"Stern","year":"2004","journal-title":"J Invest Dermatol Symp Proc"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1550-8579(04)80017-2","article-title":"Does visible atopic dermatitis affect quality of life more in women than in men?","volume":"1","author":"Holm","year":"2004","journal-title":"Gend Med"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.138.3.337","article-title":"Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance","volume":"138","author":"Renzi","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1365-2133.2005.06876.x","article-title":"Does enough quality of life related discussion occur during dermatology outpatient consultations?","volume":"153","author":"David","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"Ten years' experience of the Dermatology Life Quality Index (DLQI)","volume":"9","author":"Lewis","year":"2004","journal-title":"J Invest Dermatol Symp Proc"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2006.07343.x-BIB20|cit20","article-title":"Clinical responses to treatment and changes in the dermatology life quality index (DLQI) in moderate to severe plaque psoriasis patients treated with adalimumab","volume":"19","author":"Melilli","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2005.06502.x","article-title":"Current severe psoriasis and the rule of tens","volume":"152","author":"Finlay","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2005.06893.x","article-title":"British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005","volume":"153","author":"Smith","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2133.1999.02977.x","article-title":"Intermittent short courses of cyclosporin (Neoral\u00ae) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomised study","volume":"141","author":"Ho","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1365-2133.2001.04183.x","article-title":"Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin","volume":"144","author":"Touw","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB25|cit25","unstructured":"Vanaclocha F Puig L Daud\u00e9n E et\u00a0al."},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB26|cit26","unstructured":"Puig L Vanaclocha F Daud\u00e9n E et\u00a0al."},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.1993.tb03170.x","article-title":"Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized double blind placebo-controlled trial","volume":"129","author":"Salek","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2133.2000.03241.x","article-title":"Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy","volume":"142","author":"Harper","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB29|cit29","first-page":"653","article-title":"A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves quality of life","volume":"42","author":"Czech","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB30|cit30","first-page":"581","article-title":"Patients with psoriasis and their compliance with medication","volume":"41","author":"Richards","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 67","key":"10.1111\/j.1365-2133.2006.07343.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.0366-077X.2004.05950.x","article-title":"The use of ciclosporin in psoriasis: a clinical review","volume":"150","author":"Ho","year":"2004","journal-title":"Br J Dermatol"},{"issue":"Suppl. 67","key":"10.1111\/j.1365-2133.2006.07343.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/j.0366-077X.2004.05949.x","article-title":"Ciclosporin in psoriasis clinical practice: an international consensus statement","volume":"150","author":"Griffiths","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM197909063011015","article-title":"Ciclosporin A for psoriasis","volume":"301","author":"M\u00fcller","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM199101313240501","article-title":"Cyclosporine for plaque-type psoriasis: results of a multi-dose, double-blind trial","volume":"324","author":"Ellis","year":"1991","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2006.07343.x-BIB35|cit35","volume-title":"Dermatology","volume":"187","author":"Finzi","year":"1993"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB36|cit36","first-page":"527","article-title":"Treatment of psoriasis with intermittent short-course cyclosporin (Neoral\u00ae). A multicentre study","volume":"136","author":"Berth-Jones","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1067\/mjd.2001.112400","article-title":"Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study","volume":"44","author":"Ho","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00128071-200102010-00007","article-title":"Cyclosporine in severe psoriasis: results of a meta-analysis","volume":"2","author":"Faerber","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0190-9622(97)80219-8","article-title":"Cyclosporine as maintenance therapy in patients with severe psoriasis","volume":"36","author":"Shupack","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0190-9622(95)91393-9","article-title":"Long-term maintenance therapy with cyclosporine and post-treatment survey in severe psoriasis: results of a multicenter study. German Multicenter Study","volume":"33","author":"Mrowietz","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0190-9622(92)70012-5","article-title":"Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis","volume":"26","author":"Christophers","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2133.1990.tb02877.x","article-title":"Four years of experience with cyclosporin A for psoriasis","volume":"36","author":"Powles","year":"1990","journal-title":"Br J Dermatol Supplement"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archderm.1995.01690190043008","article-title":"Duration of remission during maintenance ciclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy","volume":"131","author":"Ellis","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1365-2133.1998.02319.x","article-title":"A randomised, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis","volume":"139","author":"Koo","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2230.2002.00998.x","article-title":"Adverse effects with long-term cyclosporin for severe psoriasis","volume":"27","author":"Markham","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1468-3083.2004.00877.x","article-title":"Safety of long-term treatment with cyclosporin A in resistant chronic plaque psoriasis: a retrospective case series","volume":"18","author":"Garcia-Bustinduy","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0190-9622(08)80694-9","article-title":"Rapid response of von Zumbusch psoriasis to ciclosporine","volume":"23","author":"Fradin","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2230.2001.00835.x","article-title":"Advances in systemic therapy for psoriasis","volume":"26","author":"Mrowietz","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-2230.2002.01171.x","article-title":"Treatment targeted to cell surface epitopes","volume":"27","author":"Mrowietz","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2133.2000.03670.x","article-title":"Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis","volume":"143","author":"Davison","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB52|cit52","first-page":"2274","article-title":"A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis","volume":"28","author":"Salvarani","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00296-001-0166-7","article-title":"Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis","volume":"21","author":"Sarzi-Puttini","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2004.024463","article-title":"A randomised, double blind, placebo controlled multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis","volume":"64","author":"Fraser","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/000155501750208137","article-title":"Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis","volume":"81","author":"Granlund","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00019053-200321030-00002","article-title":"Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids","volume":"21","author":"Schiffner","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1542\/peds.105.4.794","article-title":"Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis","volume":"105","author":"Ellison","year":"2000","journal-title":"Paediatrics"},{"issue":"Suppl. 63","key":"10.1111\/j.1365-2133.2006.07343.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.148.s63.1.x","article-title":"International consensus conference in atopic dermatitis II (ICCAD II): clinical update and current treatment strategies","volume":"148","author":"Ellis","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB59|cit59","first-page":"244","article-title":"Stable incidence of atopic dermatitis among children in Denmark during the 1990s","volume":"85","author":"Olesen","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archderm.1987.01660260034008","article-title":"Efficacy of low-dose cyclosporin in severe atopic skin disease","volume":"123","author":"Van Joost","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(91)90134-B","article-title":"Double-blind controlled crossover study of cyclosporin in adults with severe atopic dermatitis","volume":"338","author":"Sowden","year":"1991","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000051358","article-title":"Cyclosporin A treatment of children with severe atopic dermatitis improves quality of life of their mothers","volume":"3","author":"Von R\u00fcden","year":"2002","journal-title":"Dermatol Psychosom"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB63|cit63","volume-title":"Dermatology (on-Line)","author":"Bolognia","year":"2003"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09546630410031909","article-title":"Review of 26 cases of classical pyoderma gangrenosum: clinical and therapuetic features","volume":"15","author":"Vidal","year":"2004","journal-title":"J Dermatol Treat"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00054725-200102000-00001","article-title":"Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease","volume":"7","author":"Friedman","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1365-2133.1998.02555.x","article-title":"Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis","volume":"139","author":"Erkko","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"159","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0190-9622(08)81506-X","article-title":"The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study","volume":"30","author":"Lapidoth","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB70|cit70","first-page":"3319","article-title":"Lichen planus","volume":"61","author":"Katta","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0190-9622(90)70009-7","article-title":"Treatment of severe lichen planus with ciclosporine","volume":"22","author":"Ho","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0002-9394(03)00147-8","article-title":"Lichen planus and cicatrizing conjunctivitis: characterization of five cases","volume":"136","author":"Thorne","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199008023230502","article-title":"Effect of topical ciclosporine rinse on oral lichen planus: a double-blind analysis","volume":"323","author":"Eisen","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-4362.2000.00863.x","article-title":"Corticosteroid-resistant erosive oral lichen planus successfully treated with topical cyclosporine therapy","volume":"39","author":"Demitsu","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1468-3083.2001.00129-3.x","article-title":"Treatment of plantar erosive lichen planus with topical cyclosporin","volume":"15","author":"Pacj","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1067\/S0190-9622(03)00873-9","article-title":"Short course of oral cyclosporine in lichen planopilaris","volume":"49","author":"Mirmirani","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0190-9622(91)70308-O","article-title":"Oral ciclosporine for severe chronic idiopathic urticaria and angioedema","volume":"25","author":"Fradin","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB78|cit78","first-page":"285","article-title":"Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation","volume":"24","author":"Di Gioacchino","year":"2003","journal-title":"Allergy Asthma Proc"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized double-blind study of cyclosporin in chronic \u2018idiopathic\u2019 urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1067\/mjd.2001.113693","article-title":"Emerging treatment for epidermolysis bullosa acquisita","volume":"44","author":"Engineer","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/rheumatology\/39.8.865","article-title":"Cyclosporin and tacrolimus: their use in a routine clinical setting for scleroderma","volume":"39","author":"Morton","year":"2000","journal-title":"Rheumatology"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/09546630305546","article-title":"Severe resistant subacute prurigo successfully controlled by long-term cyclosporin","volume":"14","author":"Dauden","year":"2003","journal-title":"J Dermatol Treat"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB83|cit83","first-page":"1287","article-title":"Transplantation: toxicokinetics and mechanisms of toxicity of cyclosporine and macrolides","volume":"4","author":"Serkova","year":"2003","journal-title":"Curr Opin Invest Drugs"},{"issue":"Suppl. 26","key":"10.1111\/j.1365-2133.2006.07343.x-BIB84|cit84","first-page":"1","article-title":"A consensus report: cyclosporin A therapy for psoriasis","volume":"122","author":"Mihatsch","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ki.1994.387","article-title":"A prospective study of renal structure and function in psoriasis patients treated with ciclosporin","volume":"46","author":"Young","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1056\/NEJM199206183262502","article-title":"Risk factors for cyclosporin-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporin in Autoimmune Diseases","volume":"326","author":"Feutren","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0190-9622(96)90726-4","article-title":"Long-term low-dose cyclosporine therapy for severe psoriasis. Effects on renal function and structure","volume":"35","author":"Lowe","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1523-1747.2003.12040.x","article-title":"Risk of malignancies in psoriasis treated with cyclosporine: a 5-yr cohort study","volume":"120","author":"Paul","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0140-6736(01)06179-7","article-title":"Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study","volume":"358","author":"Marcil","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.tp.0000188688.15639.03","article-title":"Does bioequivalence between modified cyclosporine formulations translate into equal outcomes?","volume":"80","author":"Taber","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00007691-199708000-00002","article-title":"Simple bioequivalence criteria: are they relevant to critical dose drugs? Experience gained from cyclosporine","volume":"19","author":"Johnston","year":"1997","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0041-1345(99)00085-8","article-title":"Bioequivalence criteria for cyclosporine","volume":"31","author":"Johnston","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0149-2918(03)80161-3","article-title":"A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A","volume":"25","author":"Pollard","year":"2003","journal-title":"Clin Ther"},{"key":"10.1111\/j.1365-2133.2006.07343.x-BIB94|cit94","unstructured":"British National Formulary. Corticosteroids and Other Immunosuppressants-Ciclosporin 50 http:\/\/www.bnf.org"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07343.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07343.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2006.07343.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:17:33Z","timestamp":1676384253000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/155\/s2\/1\/6636482"}},"subtitle":["Ciclosporin use in immune-mediated dermatoses"],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":94,"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07343.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}